Bellicum Pharmaceuticals Inc. buy stratec
Start price
04.01.18
/
50%
€84.25
Target price
03.12.18
€180.40
Performance (%)
-47.97%
End price
03.12.18
€43.84
Summary
This prediction ended on 03.12.18 with a price of €43.84. Massive losses of -47.97% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bellicum Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 1,43 % | 2,63 % | 12,46 % | 60,35 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % | 1,25 % | 85,81 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % | 27,38 % | 64,40 % |
| iShares S&P 500 | 1,92 % | 1,16 % | 1,63 % | 59,42 % |
Comments by stratec for this prediction
In the thread Bellicum Pharmaceuticals Inc. diskutieren
stratec stimmt der Buy-Einschätzung von tamam zu
stratec stimmt am 04.01.2018 der Buy-Einschätzung von tamam mit dem Kursziel 20$ zu.Überschrift: BLCM´s Ziel: eine broad-label-approval zur Behandlung von bösartigen und nicht-malignen Blutkrankheiten
(Vom Mitglied beendet)
Stopped prediction by stratec for Bellicum Pharmaceuticals Inc.
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.75
08.03.20
08.03.20
€12.00
21.03.20
21.03.20
-49.63%
21.03.20
21.03.20
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.80
23.02.20
23.02.20
€12.00
08.03.20
08.03.20
-1.54%
08.03.20
08.03.20
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.20
08.02.20
08.02.20
€12.00
22.02.20
22.02.20
-23.53%
22.02.20
22.02.20
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€12.20
06.01.20
06.01.20
€20.00
08.02.20
08.02.20
-16.39%
08.02.20
08.02.20
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.65
12.11.19
12.11.19
€10.00
31.12.19
31.12.19
55.56%
31.12.19
31.12.19
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€43.84
02.12.18
02.12.18
€72.16
12.11.19
12.11.19
-82.55%
12.11.19
12.11.19